Click for best price
Diabetic Gastroparesis Drugs Market Size, Share 2023
Diabetic gastroparesis refers to cases of the digestive condition gastroparesis that diabetes causes.
This report aims to provide a comprehensive presentation of the global market for Diabetic Gastroparesis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Gastroparesis Drugs. This report contains market size and forecasts of Diabetic Gastroparesis Drugs in global, including the following market information:
Global Diabetic Gastroparesis Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Diabetic Gastroparesis Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Prokinetic Agents Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Diabetic Gastroparesis Drugs include Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva, Johnson & Johnson, Pfizer, Kyowa Kirin Pharmaceuticals, Hanmi Pharm and Ani Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diabetic Gastroparesis Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetic Gastroparesis Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Diabetic Gastroparesis Drugs Market Segment Percentages, by Type, 2022 (%)
Prokinetic Agents
Antiemetic Agents
Others
Global Diabetic Gastroparesis Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Diabetic Gastroparesis Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Private Clinics
Drug Stores
E-Commerce
Global Diabetic Gastroparesis Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Diabetic Gastroparesis Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetic Gastroparesis Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Diabetic Gastroparesis Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Diabetic Gastroparesis Drugs, market overview.
Chapter 2: Global Diabetic Gastroparesis Drugs market size in revenue.
Chapter 3: Detailed analysis of Diabetic Gastroparesis Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diabetic Gastroparesis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Diabetic Gastroparesis Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Diabetic Gastroparesis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diabetic Gastroparesis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diabetic Gastroparesis Drugs Overall Market Size
2.1 Global Diabetic Gastroparesis Drugs Market Size: 2022 VS 2029
2.2 Global Diabetic Gastroparesis Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Diabetic Gastroparesis Drugs Players in Global Market
3.2 Top Global Diabetic Gastroparesis Drugs Companies Ranked by Revenue
3.3 Global Diabetic Gastroparesis Drugs Revenue by Companies
3.4 Top 3 and Top 5 Diabetic Gastroparesis Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Diabetic Gastroparesis Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetic Gastroparesis Drugs Players in Global Market
3.6.1 List of Global Tier 1 Diabetic Gastroparesis Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Diabetic Gastroparesis Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Diabetic Gastroparesis Drugs Market Size Markets, 2022 & 2029
4.1.2 Prokinetic Agents
4.1.3 Antiemetic Agents
4.1.4 Others
4.2 By Type - Global Diabetic Gastroparesis Drugs Revenue & Forecasts
4.2.1 By Type - Global Diabetic Gastroparesis Drugs Revenue, 2018-2023
4.2.2 By Type - Global Diabetic Gastroparesis Drugs Revenue, 2024-2029
4.2.3 By Type - Global Diabetic Gastroparesis Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Diabetic Gastroparesis Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Private Clinics
5.1.4 Drug Stores
5.1.5 E-Commerce
5.2 By Application - Global Diabetic Gastroparesis Drugs Revenue & Forecasts
5.2.1 By Application - Global Diabetic Gastroparesis Drugs Revenue, 2018-2023
5.2.2 By Application - Global Diabetic Gastroparesis Drugs Revenue, 2024-2029
5.2.3 By Application - Global Diabetic Gastroparesis Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Diabetic Gastroparesis Drugs Market Size, 2022 & 2029
6.2 By Region - Global Diabetic Gastroparesis Drugs Revenue & Forecasts
6.2.1 By Region - Global Diabetic Gastroparesis Drugs Revenue, 2018-2023
6.2.2 By Region - Global Diabetic Gastroparesis Drugs Revenue, 2024-2029
6.2.3 By Region - Global Diabetic Gastroparesis Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Diabetic Gastroparesis Drugs Revenue, 2018-2029
6.3.2 US Diabetic Gastroparesis Drugs Market Size, 2018-2029
6.3.3 Canada Diabetic Gastroparesis Drugs Market Size, 2018-2029
6.3.4 Mexico Diabetic Gastroparesis Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Diabetic Gastroparesis Drugs Revenue, 2018-2029
6.4.2 Germany Diabetic Gastroparesis Drugs Market Size, 2018-2029
6.4.3 France Diabetic Gastroparesis Drugs Market Size, 2018-2029
6.4.4 U.K. Diabetic Gastroparesis Drugs Market Size, 2018-2029
6.4.5 Italy Diabetic Gastroparesis Drugs Market Size, 2018-2029
6.4.6 Russia Diabetic Gastroparesis Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Diabetic Gastroparesis Drugs Market Size, 2018-2029
6.4.8 Benelux Diabetic Gastroparesis Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Diabetic Gastroparesis Drugs Revenue, 2018-2029
6.5.2 China Diabetic Gastroparesis Drugs Market Size, 2018-2029
6.5.3 Japan Diabetic Gastroparesis Drugs Market Size, 2018-2029
6.5.4 South Korea Diabetic Gastroparesis Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Diabetic Gastroparesis Drugs Market Size, 2018-2029
6.5.6 India Diabetic Gastroparesis Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Diabetic Gastroparesis Drugs Revenue, 2018-2029
6.6.2 Brazil Diabetic Gastroparesis Drugs Market Size, 2018-2029
6.6.3 Argentina Diabetic Gastroparesis Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Diabetic Gastroparesis Drugs Revenue, 2018-2029
6.7.2 Turkey Diabetic Gastroparesis Drugs Market Size, 2018-2029
6.7.3 Israel Diabetic Gastroparesis Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Diabetic Gastroparesis Drugs Market Size, 2018-2029
6.7.5 UAE Diabetic Gastroparesis Drugs Market Size, 2018-2029
7 Diabetic Gastroparesis Drugs Companies Profiles
7.1 Sumitomo
7.1.1 Sumitomo Company Summary
7.1.2 Sumitomo Business Overview
7.1.3 Sumitomo Diabetic Gastroparesis Drugs Major Product Offerings
7.1.4 Sumitomo Diabetic Gastroparesis Drugs Revenue in Global Market (2018-2023)
7.1.5 Sumitomo Key News & Latest Developments
7.2 Cadila Pharmaceuticals
7.2.1 Cadila Pharmaceuticals Company Summary
7.2.2 Cadila Pharmaceuticals Business Overview
7.2.3 Cadila Pharmaceuticals Diabetic Gastroparesis Drugs Major Product Offerings
7.2.4 Cadila Pharmaceuticals Diabetic Gastroparesis Drugs Revenue in Global Market (2018-2023)
7.2.5 Cadila Pharmaceuticals Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Diabetic Gastroparesis Drugs Major Product Offerings
7.3.4 Sanofi Diabetic Gastroparesis Drugs Revenue in Global Market (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Teva
7.4.1 Teva Company Summary
7.4.2 Teva Business Overview
7.4.3 Teva Diabetic Gastroparesis Drugs Major Product Offerings
7.4.4 Teva Diabetic Gastroparesis Drugs Revenue in Global Market (2018-2023)
7.4.5 Teva Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Diabetic Gastroparesis Drugs Major Product Offerings
7.5.4 Johnson & Johnson Diabetic Gastroparesis Drugs Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Diabetic Gastroparesis Drugs Major Product Offerings
7.6.4 Pfizer Diabetic Gastroparesis Drugs Revenue in Global Market (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Kyowa Kirin Pharmaceuticals
7.7.1 Kyowa Kirin Pharmaceuticals Company Summary
7.7.2 Kyowa Kirin Pharmaceuticals Business Overview
7.7.3 Kyowa Kirin Pharmaceuticals Diabetic Gastroparesis Drugs Major Product Offerings
7.7.4 Kyowa Kirin Pharmaceuticals Diabetic Gastroparesis Drugs Revenue in Global Market (2018-2023)
7.7.5 Kyowa Kirin Pharmaceuticals Key News & Latest Developments
7.8 Hanmi Pharm
7.8.1 Hanmi Pharm Company Summary
7.8.2 Hanmi Pharm Business Overview
7.8.3 Hanmi Pharm Diabetic Gastroparesis Drugs Major Product Offerings
7.8.4 Hanmi Pharm Diabetic Gastroparesis Drugs Revenue in Global Market (2018-2023)
7.8.5 Hanmi Pharm Key News & Latest Developments
7.9 Ani Pharmaceuticals
7.9.1 Ani Pharmaceuticals Company Summary
7.9.2 Ani Pharmaceuticals Business Overview
7.9.3 Ani Pharmaceuticals Diabetic Gastroparesis Drugs Major Product Offerings
7.9.4 Ani Pharmaceuticals Diabetic Gastroparesis Drugs Revenue in Global Market (2018-2023)
7.9.5 Ani Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Diabetic Gastroparesis Drugs Market Opportunities & Trends in Global Market
Table 2. Diabetic Gastroparesis Drugs Market Drivers in Global Market
Table 3. Diabetic Gastroparesis Drugs Market Restraints in Global Market
Table 4. Key Players of Diabetic Gastroparesis Drugs in Global Market
Table 5. Top Diabetic Gastroparesis Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Diabetic Gastroparesis Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Diabetic Gastroparesis Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Diabetic Gastroparesis Drugs Product Type
Table 9. List of Global Tier 1 Diabetic Gastroparesis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetic Gastroparesis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Diabetic Gastroparesis Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Diabetic Gastroparesis Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Diabetic Gastroparesis Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Diabetic Gastroparesis Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Diabetic Gastroparesis Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Diabetic Gastroparesis Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Sumitomo Company Summary
Table 31. Sumitomo Diabetic Gastroparesis Drugs Product Offerings
Table 32. Sumitomo Diabetic Gastroparesis Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Sumitomo Key News & Latest Developments
Table 34. Cadila Pharmaceuticals Company Summary
Table 35. Cadila Pharmaceuticals Diabetic Gastroparesis Drugs Product Offerings
Table 36. Cadila Pharmaceuticals Diabetic Gastroparesis Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Cadila Pharmaceuticals Key News & Latest Developments
Table 38. Sanofi Company Summary
Table 39. Sanofi Diabetic Gastroparesis Drugs Product Offerings
Table 40. Sanofi Diabetic Gastroparesis Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Sanofi Key News & Latest Developments
Table 42. Teva Company Summary
Table 43. Teva Diabetic Gastroparesis Drugs Product Offerings
Table 44. Teva Diabetic Gastroparesis Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Teva Key News & Latest Developments
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Diabetic Gastroparesis Drugs Product Offerings
Table 48. Johnson & Johnson Diabetic Gastroparesis Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Diabetic Gastroparesis Drugs Product Offerings
Table 52. Pfizer Diabetic Gastroparesis Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Kyowa Kirin Pharmaceuticals Company Summary
Table 55. Kyowa Kirin Pharmaceuticals Diabetic Gastroparesis Drugs Product Offerings
Table 56. Kyowa Kirin Pharmaceuticals Diabetic Gastroparesis Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Kyowa Kirin Pharmaceuticals Key News & Latest Developments
Table 58. Hanmi Pharm Company Summary
Table 59. Hanmi Pharm Diabetic Gastroparesis Drugs Product Offerings
Table 60. Hanmi Pharm Diabetic Gastroparesis Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Hanmi Pharm Key News & Latest Developments
Table 62. Ani Pharmaceuticals Company Summary
Table 63. Ani Pharmaceuticals Diabetic Gastroparesis Drugs Product Offerings
Table 64. Ani Pharmaceuticals Diabetic Gastroparesis Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Ani Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Diabetic Gastroparesis Drugs Segment by Type in 2022
Figure 2. Diabetic Gastroparesis Drugs Segment by Application in 2022
Figure 3. Global Diabetic Gastroparesis Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Diabetic Gastroparesis Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Diabetic Gastroparesis Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetic Gastroparesis Drugs Revenue in 2022
Figure 8. By Type - Global Diabetic Gastroparesis Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Diabetic Gastroparesis Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Diabetic Gastroparesis Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Diabetic Gastroparesis Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Diabetic Gastroparesis Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Diabetic Gastroparesis Drugs Revenue Market Share, 2018-2029
Figure 16. US Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Diabetic Gastroparesis Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Diabetic Gastroparesis Drugs Revenue Market Share, 2018-2029
Figure 28. China Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Diabetic Gastroparesis Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Diabetic Gastroparesis Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Diabetic Gastroparesis Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Sumitomo Diabetic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Cadila Pharmaceuticals Diabetic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sanofi Diabetic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Teva Diabetic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson & Johnson Diabetic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pfizer Diabetic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Kyowa Kirin Pharmaceuticals Diabetic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Hanmi Pharm Diabetic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Ani Pharmaceuticals Diabetic Gastroparesis Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
